Omico proves its worth again, and again

By Megan Brodie 2 years ago | In Patients
  • 2 years ago
Omico's Professor David Thomas (left) with RCA CEO Christine Cockburn and Health Minister Mark Butler. Source: LinkedIn

21 August 2024 A retrospective analysis of data from Omico’s MoST (Molecular Screening and Therapeutics…

This is subscriber-only content. Please login to continue reading.